370 related articles for article (PubMed ID: 26948291)
1. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
[TBL] [Abstract][Full Text] [Related]
2. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
3. Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction.
Cheng L; Tang YQ; Yi J; Ren Q; Yang XY; Gou SJ; Zhang L; Fu P
Blood Purif; 2020; 49(6):713-722. PubMed ID: 32294643
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
5. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
de Joode AA; Sanders JS; Smid WM; Stegeman CA
J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
[TBL] [Abstract][Full Text] [Related]
7. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy.
Merino JL; Galeano C; Espejo B; Rivera M; Fernández-Lucas M; Caldés S; Plana MN; Letosa M; Teruel JL; Quereda C; Ortuño J
Nephrol Dial Transplant; 2011 Apr; 26(4):1360-6. PubMed ID: 20810451
[TBL] [Abstract][Full Text] [Related]
11. Renal vasculitis presenting with acute kidney injury.
Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients.
Chen Y; Ding Y; Liu Z; Zhang H; Liu Z; Hu W
BMC Nephrol; 2016 Jul; 17(1):101. PubMed ID: 27461086
[TBL] [Abstract][Full Text] [Related]
13. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.
Kouri AM; Andreoli SP
Pediatr Nephrol; 2017 Mar; 32(3):449-455. PubMed ID: 27677979
[TBL] [Abstract][Full Text] [Related]
15. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis and its risk factors in ANCA-associated glomerulonephritis patients treated with initial renal replacement therapy].
Chen YH; Liu X; Liu ZZ; Li K; Yang L; Zhang HT; Zeng CH; Xu F; Hu WX
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):274-279. PubMed ID: 29397613
[No Abstract] [Full Text] [Related]
19. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
[TBL] [Abstract][Full Text] [Related]
20. Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Wang C; Gou SJ; Chang DY; Yu F; Zhao MH; Chen M
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1828-34. PubMed ID: 24591411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
